These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8191244)

  • 1. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies.
    Rintala E
    Scand J Infect Dis; 1994; 26(1):77-84. PubMed ID: 8191244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of measurement of C-reactive protein in febrile patients with hematological malignancies.
    Rintala E; Irjala K; Nikoskelainen J
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):973-8. PubMed ID: 1295765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
    Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
    Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Chemotherapy-Induced Febrile Neutropenic Episodes Into One of the Three Febrile Neutropenic Syndromes.
    Raheja R; Reddy N; Patel T; Kilambi S; Mathew AA; Majeed A
    Cureus; 2023 Aug; 15(8):e42843. PubMed ID: 37664262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of febrile episodes in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation].
    Fernández-Mosteirín N; Salvador-Osuna C; Gimeno Lozano JJ; Marco Lamata ML; Blasco Alberdi M; Rubio Félix D; Giralt Raichs M
    An Med Interna; 2005 May; 22(5):213-6. PubMed ID: 16001935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections of febrile neutropenic patients in malignant hematological diseases.
    Rókusz L; Liptay L
    Mil Med; 2003 May; 168(5):355-9. PubMed ID: 12775168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients.
    Kar YD; Özdemir ZC; Bör Ö
    Turk Pediatri Ars; 2017 Dec; 52(4):213-220. PubMed ID: 29483801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
    Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
    Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
    Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
    Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of febrile neutropenia with cefepime monotherapy.
    Jándula BM; Martino R; Gurgi M; Manteiga R; Sierra J
    Chemotherapy; 2001; 47(3):226-31. PubMed ID: 11306793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
    Menichetti F; Del Favero A; Bucaneve G; Aversa F; Fiorio M
    Br J Haematol; 1990 Dec; 76 Suppl 2():45-8. PubMed ID: 2149052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation].
    Zikesoá E; Hnátková M; Vacková B; Jedlicková A; Klener P; Trnený M
    Cas Lek Cesk; 2006; 145(5):383-6, 388-9. PubMed ID: 16755776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.
    Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tanihara A; Kanda Y
    Infect Dis (Lond); 2017 Oct; 49(10):748-757. PubMed ID: 28631944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia.
    Bauduer F; Cousin T; Boulat O; Rigal-Huguet F; Molina L; Fegueux N; Jourdan E; Boiron JM; Reiffers J;
    Leuk Lymphoma; 2001 Jul; 42(3):379-86. PubMed ID: 11699402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition.
    Jones GR; Konsler GK; Dunaway RP; Gold SH; Cooper HA; Wells RJ
    J Pediatr; 1994 May; 124(5 Pt 1):703-8. PubMed ID: 8176555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies.
    Rintala E; Pulkki K; Mertsola J; Nevalainen T; Nikoskelainen J
    Scand J Infect Dis; 1995; 27(1):39-43. PubMed ID: 7784812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
    Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
    Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
    Ali N; Adil SN; Shaikh MU
    Transpl Infect Dis; 2014 Feb; 16(1):98-105. PubMed ID: 24383473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.